State Street’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,763,828
| Closed | -$267M | – | 5008 |
|
2022
Q3 | $267M | Buy |
1,763,828
+18,782
| +1% | +$2.84M | 0.02% | 634 |
|
2022
Q2 | $254M | Buy |
1,745,046
+89,212
| +5% | +$13M | 0.02% | 656 |
|
2022
Q1 | $196M | Buy |
1,655,834
+8,140
| +0.5% | +$965K | 0.01% | 844 |
|
2021
Q4 | $227M | Buy |
1,647,694
+162,764
| +11% | +$22.4M | 0.01% | 795 |
|
2021
Q3 | $206M | Buy |
1,484,930
+4,363
| +0.3% | +$606K | 0.01% | 820 |
|
2021
Q2 | $144M | Sell |
1,480,567
-54,177
| -4% | -$5.26M | 0.01% | 1045 |
|
2021
Q1 | $105M | Sell |
1,534,744
-137,205
| -8% | -$9.38M | 0.01% | 1197 |
|
2020
Q4 | $143M | Sell |
1,671,949
-101,223
| -6% | -$8.68M | 0.01% | 909 |
|
2020
Q3 | $115M | Buy |
1,773,172
+2,463
| +0.1% | +$160K | 0.01% | 891 |
|
2020
Q2 | $129M | Sell |
1,770,709
-205,232
| -10% | -$15M | 0.01% | 822 |
|
2020
Q1 | $67.2M | Buy |
1,975,941
+64,533
| +3% | +$2.2M | 0.01% | 1067 |
|
2019
Q4 | $104M | Sell |
1,911,408
-133,535
| -7% | -$7.27M | 0.01% | 1024 |
|
2019
Q3 | $85.3M | Buy |
2,044,943
+456,986
| +29% | +$19.1M | 0.01% | 1101 |
|
2019
Q2 | $69.5M | Buy |
1,587,957
+248,909
| +19% | +$10.9M | 0.01% | 1265 |
|
2019
Q1 | $68.9M | Buy |
1,339,048
+327,534
| +32% | +$16.9M | 0.01% | 1258 |
|
2018
Q4 | $37.4M | Sell |
1,011,514
-310,841
| -24% | -$11.5M | ﹤0.01% | 1542 |
|
2018
Q3 | $49.7M | Sell |
1,322,355
-168,597
| -11% | -$6.33M | ﹤0.01% | 1541 |
|
2018
Q2 | $58.9M | Buy |
1,490,952
+982,149
| +193% | +$38.8M | ﹤0.01% | 1378 |
|
2018
Q1 | $13.1M | Buy |
508,803
+329,986
| +185% | +$8.5M | ﹤0.01% | 2332 |
|
2017
Q4 | $4.82M | Buy |
178,817
+18,042
| +11% | +$487K | ﹤0.01% | 2810 |
|
2017
Q3 | $6.01M | Buy |
160,775
+43,563
| +37% | +$1.63M | ﹤0.01% | 2703 |
|
2017
Q2 | $2.93M | Buy |
+117,212
| New | +$2.93M | ﹤0.01% | 2979 |
|